The SLT LASER is used for both the initial and follow-up treatment of open angle glaucoma. It is the most recent addition to Eye Health's arsenal of lasers and was introduced in 2005. The SLT Laser has replaced the Argon Laser as the laser of choice for chronic open angle glaucoma (see article on SLT laser).

The ENDOSCOPIC CYCLO PHOTOCOAGULATION (ECP) LASER is used for the treatment of chronic glaucoma for patients undergoing or having already undergone Cataract Surgery. ECP is utilized during cataract surgery to achieve better pressure control in glaucoma patients already on eye drops. It was introduced at Eye Health in 2003.

The LUMENIS OPAL LASER is used to deliver Photo-Dynamic Therapy (PDT) for the expanded treatment of macular degeneration. Depending upon the stage and type of macular degeneration one of three different lasers may be used: The Opal Laser for PDT, Transpupillary Thermo-therapy (TTT) or Argon Laser. The Opal Laser arrived at Eye Health in 2002.

The TRANSPUPILLARY THERMO-THERAPY (TTT) LASER is also used for the expanded treatment of macular degeneration. This laser was introduced at Eye Health in 2000. The EXCIMER LASER is used for Laser Vision Correction (PRK and LASIK). It was introduced at Eye Health Vision Center in 1999. LASIK for the correction of nearsightedness, farsightedness and astigmatism has been progressively growing in popularity over the past ten years.

The YAG LASER is used for the treatment of capsular scar tissue, which often causes blurred vision following cataract removal. It was introduced at Eye Health Vision Center in 1985. This is the most common laser treatment performed at Eye Health.

The ARGON LASER is used for the treatment of narrow angle glaucoma, diabetes, other retinal conditions and select forms of wet macular degeneration. This was Eye Health's very first type of laser and was introduced to the practice in 1980. It remains the primary laser used in treating diabetic retinopathy and retinal tears, but has recently been replaced by the SLT laser as Eye Health's choice for the treatment of chronic open angle glaucoma.